Precigen Inc (PGEN)
1.40
+0.02
(+1.45%)
USD |
NASDAQ |
Apr 23, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Precigen Price to Book Value: 2.941 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 2.941 |
April 22, 2024 | 2.899 |
April 19, 2024 | 2.794 |
April 18, 2024 | 2.773 |
April 17, 2024 | 2.752 |
April 16, 2024 | 2.857 |
April 15, 2024 | 2.941 |
April 12, 2024 | 2.983 |
April 11, 2024 | 3.046 |
April 10, 2024 | 2.962 |
April 09, 2024 | 2.962 |
April 08, 2024 | 2.962 |
April 05, 2024 | 2.941 |
April 04, 2024 | 2.857 |
April 03, 2024 | 2.941 |
April 02, 2024 | 2.920 |
April 01, 2024 | 3.004 |
March 28, 2024 | 3.046 |
March 27, 2024 | 3.046 |
March 26, 2024 | 2.941 |
March 25, 2024 | 2.951 |
March 22, 2024 | 2.930 |
March 21, 2024 | 3.214 |
March 20, 2024 | 3.025 |
March 19, 2024 | 3.025 |
Date | Value |
---|---|
March 18, 2024 | 2.920 |
March 15, 2024 | 3.004 |
March 14, 2024 | 3.004 |
March 13, 2024 | 3.193 |
March 12, 2024 | 3.161 |
March 11, 2024 | 3.266 |
March 08, 2024 | 3.676 |
March 07, 2024 | 3.508 |
March 06, 2024 | 3.529 |
March 05, 2024 | 3.382 |
March 04, 2024 | 3.424 |
March 01, 2024 | 3.55 |
February 29, 2024 | 3.235 |
February 28, 2024 | 3.193 |
February 27, 2024 | 3.403 |
February 26, 2024 | 3.214 |
February 23, 2024 | 3.067 |
February 22, 2024 | 3.025 |
February 21, 2024 | 2.983 |
February 20, 2024 | 2.983 |
February 16, 2024 | 2.983 |
February 15, 2024 | 3.004 |
February 14, 2024 | 2.941 |
February 13, 2024 | 2.752 |
February 12, 2024 | 3.004 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.339
Minimum
Apr 12 2023
33.46
Maximum
Dec 28 2020
7.154
Average
4.348
Median
Aug 07 2019
Price to Book Value Benchmarks
Cyclacel Pharmaceuticals Inc | 3.974 |
HealthEquity Inc | 3.382 |
Corvus Pharmaceuticals Inc | 1.940 |
Oragenics Inc | 3.100 |
MAIA Biotechnology Inc | 106.03 |
Price to Book Value Related Metrics
PS Ratio | 54.83 |
Price | 1.40 |
Earnings Yield | -27.86% |
Market Cap | 348.49M |